0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From the Centers for Disease Control and Prevention |

Update: Severe Acute Respiratory Syndrome—United States, May 21, 2003 FREE

JAMA. 2003;289(22):2932. doi:10.1001/jama.289.22.2932-a.
Text Size: A A A
Published online

UPDATE: SEVERE ACUTE RESPIRATORY SYNDROME—UNITED STATES, MAY 21, 2003

MMWR. 2003;52:466-468

1 figure, 1 table omitted

CDC continues to work with state and local health departments, the World Health Organization (WHO), and other partners to investigate cases of severe acute respiratory syndrome (SARS). This report updates SARS cases reported worldwide and in the United States and highlights recent modifications to the U.S. SARS case definition that define criteria for exclusion of previously reported SARS cases and for reporting travel-associated cases of SARS.

During November 1, 2002–May 21, 2003, a total of 7,956 SARS cases were reported to WHO from 28 countries, including the United States; 666 deaths (case-fatality proportion: 8.4%) have been reported.1 A total of 355 SARS cases identified in the United States have been reported from 40 states with 290 (82%) cases classified as suspect SARS and 65 (18%) classified as probable SARS (more severe illnesses characterized by the presence of pneumonia or acute respiratory distress syndrome).2 One probable and nine suspect cases have been identified since the last update.3

Of the 65 probable SARS patients, 41 (63%) were hospitalized, and two (3%) required mechanical ventilation. No SARS-related deaths have been reported in the United States. Of 65 probable cases, 63 (97%) were attributed to international travel to areas with documented or suspected community transmission of SARS within the 10 days before illness onset; the remaining two (3%) probable cases occurred in a health-care worker who provided care to a SARS patient and a household contact of a SARS patient. Among the 63 probable SARS cases attributed to travel, 33 (52%) patients reported travel to mainland China; 19 (30%) to Hong Kong Special Administrative Region, China; six (10%) to Singapore; two (3%) to Hanoi, Vietnam; nine (14%) to Toronto, Canada; and one (2%) to Taiwan. Of the probable SARS patients, five (8%) had visited more than one area with SARS during the 10 days before illness onset.

Laboratory testing to evaluate infection with the SARS-associated coronavirus (SARS-CoV) has been completed for 122 cases (26 probable and 96 suspect). Since the last update,3 the number of cases with laboratory-confirmed infection with SARS-CoV remains at six; all are probable SARS cases with no suspect SARS cases having laboratory evidence of infection with SARS-CoV. Negative findings (i.e., the absence of antibody to SARS-CoV in convalescent serum obtained >21 days after symptom onset) have been documented for 116 cases (96 suspect and 20 probable).

The number of new cases reported in the United States has been decreasing in recent weeks. The epidemiologic profile of reported cases remains unchanged with most cases associated with international travel and few instances of secondary spread to family members or other contacts. However, vigilance is critical to ensure rapid recognition and appropriate management of persons with SARS.

The low specificity of the surveillance case definition captures many persons unlikely to have SARS. The CDC surveillance case definition has been revised to include interim criteria for excluding new or previously reported suspect or probable cases of SARS for whom an alternative diagnosis can fully explain the patient's illness.2 Factors that might be considered in assigning alternative diagnoses include the strength of the epidemiologic exposure criteria for SARS, the specificity of the diagnostic tests, and the compatibility of the clinical presentation and course of illness for the alternative diagnosis. The epidemiologic criteria for travel exposure also have been revised and now reflect updated information about the occurrence of community transmission in areas with SARS. Hanoi, Vietnam and Toronto, Canada are now considered areas with previous community transmission of SARS because >30 days have elapsed since the onset of symptoms for the last reported case.4 As a result, travel alerts for these cities were removed on May 15 and May 20, respectively. Persons reporting travel to these areas will meet the surveillance case definition if illness onset occurred within 10 days (i.e., one incubation period) after removal of the travel alert.

These revisions to the case definition are for surveillance purposes only. Clinical judgment, rather than surveillance criteria, should continue to guide the management of patients and implementation of public health response measures when persons with an unknown respiratory illness are identified.

As state and local health departments review and reclassify cases using these new criteria, case counts might change but the result will more accurately reflect the occurrence of SARS in the United States.

Reported by:

State and local health departments. SARS Investigative Team, CDC.

References: 4 available

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles